Global Fetal Bovine Serum Market 2022-2026

The publisher has been monitoring the fetal bovine serum market and it is poised to grow by $ 249.72 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. The report on the fetal bovine serum market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising adoption of stem cell applications, strategic alliances among vendors, and the efficiency rate of FBS is higher than the traditional normal blood serum. The fetal bovine serum market analysis includes the application segment and geographic landscape.

The publisher's fetal bovine serum market is segmented as below:

By Application

Biopharmaceuticals
Human and animal vaccine
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing application in cell-based pharmaceutical research as one of the prime reasons driving the fetal bovine serum market growth during the next few years. Also, recent developments in FBS and an increase in support from governments to boost R&D in the pharmaceutical sector will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on the fetal bovine serum market covers the following areas:

Fetal bovine serum market sizing
Fetal bovine serum market forecast
Fetal bovine serum market industry analysis .

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fetal bovine serum market vendors that include Access Biologicals LLC, Animal Technologies Inc., Anzco Foods Ltd, Atlas Biologicals Inc., Axil Scientific Pte Ltd., Bio Techne Corp., BIOWEST SAS, Corning Inc., Danaher Corp., GeminiBio, HiMedia Laboratories Pvt. Ltd., Merck KGaA, Moregate Biotech, Nucleus Biologics, PAN Biotech GmbH, Peak Serum Inc., Rocky Mountain Biologicals LLC., Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Tissue Culture Biologicals. Also, the fetal bovine serum market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.uch as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Biopharmaceuticals - Market size and forecast 2021-2026
Exhibit 28: Chart on Biopharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Biopharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Biopharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Biopharmaceuticals - Year-over-year growth 2021-2026 (%)
5.4 Human and animal vaccine - Market size and forecast 2021-2026
Exhibit 32: Chart on Human and animal vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Human and animal vaccine - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Human and animal vaccine - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Human and animal vaccine - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Application
Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Denmark - Market size and forecast 2021-2026
Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 India - Market size and forecast 2021-2026
Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Anzco Foods Ltd
Exhibit 89: Anzco Foods Ltd - Overview
Exhibit 90: Anzco Foods Ltd - Product / Service
Exhibit 91: Anzco Foods Ltd - Key offerings
10.4 Bio Techne Corp.
Exhibit 92: Bio Techne Corp. - Overview
Exhibit 93: Bio Techne Corp. - Business segments
Exhibit 94: Bio Techne Corp. - Key news
Exhibit 95: Bio Techne Corp. - Key offerings
Exhibit 96: Bio Techne Corp. - Segment focus
10.5 BIOWEST SAS
Exhibit 97: BIOWEST SAS - Overview
Exhibit 98: BIOWEST SAS - Product / Service
Exhibit 99: BIOWEST SAS - Key offerings
10.6 Corning Inc.
Exhibit 100: Corning Inc. - Overview
Exhibit 101: Corning Inc. - Business segments
Exhibit 102: Corning Inc. - Key offerings
Exhibit 103: Corning Inc. - Segment focus
10.7 Merck KGaA
Exhibit 104: Merck KGaA - Overview
Exhibit 105: Merck KGaA - Business segments
Exhibit 106: Merck KGaA - Key news
Exhibit 107: Merck KGaA - Key offerings
Exhibit 108: Merck KGaA - Segment focus
10.8 PAN Biotech GmbH
Exhibit 109: PAN Biotech GmbH - Overview
Exhibit 110: PAN Biotech GmbH - Product / Service
Exhibit 111: PAN Biotech GmbH - Key offerings
10.9 Rocky Mountain Biologicals LLC.
Exhibit 112: Rocky Mountain Biologicals LLC. - Overview
Exhibit 113: Rocky Mountain Biologicals LLC. - Product / Service
Exhibit 114: Rocky Mountain Biologicals LLC. - Key offerings
10.10 Sartorius AG
Exhibit 115: Sartorius AG - Overview
Exhibit 116: Sartorius AG - Business segments
Exhibit 117: Sartorius AG - Key news
Exhibit 118: Sartorius AG - Key offerings
Exhibit 119: Sartorius AG - Segment focus
10.11 TCS Biosciences Ltd.
Exhibit 120: TCS Biosciences Ltd. - Overview
Exhibit 121: TCS Biosciences Ltd. - Product / Service
Exhibit 122: TCS Biosciences Ltd. - Key offerings
10.12 Thermo Fisher Scientific Inc.
Exhibit 123: Thermo Fisher Scientific Inc. - Overview
Exhibit 124: Thermo Fisher Scientific Inc. - Business segments
Exhibit 125: Thermo Fisher Scientific Inc. - Key news
Exhibit 126: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 127: Thermo Fisher Scientific Inc. - Segment focus

Exhibit 125

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 130: Currency conversion rates for US$
11.4 Research methodology
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
11.5 List of abbreviations
Exhibit 134: List of abbreviations
growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on Biopharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Biopharmaceuticals - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Biopharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Biopharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Human and animal vaccine - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Human and animal vaccine - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Human and animal vaccine - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Human and animal vaccine - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Application ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Anzco Foods Ltd - Overview
Exhibits 90: Anzco Foods Ltd - Product / Service
Exhibits 91: Anzco Foods Ltd - Key offerings
Exhibits 92: Bio Techne Corp. - Overview
Exhibits 93: Bio Techne Corp. - Business segments
Exhibits 94: Bio Techne Corp. - Key news
Exhibits 95: Bio Techne Corp. - Key offerings
Exhibits 96: Bio Techne Corp. - Segment focus
Exhibits 97: BIOWEST SAS - Overview
Exhibits 98: BIOWEST SAS - Product / Service
Exhibits 99: BIOWEST SAS - Key offerings
Exhibits 100: Corning Inc. - Overview
Exhibits 101: Corning Inc. - Business segments
Exhibits 102: Corning Inc. - Key offerings
Exhibits 103: Corning Inc. - Segment focus
Exhibits 104: Merck KGaA - Overview
Exhibits 105: Merck KGaA - Business segments
Exhibits 106: Merck KGaA - Key news
Exhibits 107: Merck KGaA - Key offerings
Exhibits 108: Merck KGaA - Segment focus
Exhibits 109: PAN Biotech GmbH - Overview
Exhibits 110: PAN Biotech GmbH - Product / Service
Exhibits 111: PAN Biotech GmbH - Key offerings
Exhibits 112: Rocky Mountain Biologicals LLC. - Overview
Exhibits 113: Rocky Mountain Biologicals LLC. - Product / Service
Exhibits 114: Rocky Mountain Biologicals LLC. - Key offerings
Exhibits 115: Sartorius AG - Overview
Exhibits 116: Sartorius AG - Business segments
Exhibits 117: Sartorius AG - Key news
Exhibits 118: Sartorius AG - Key offerings
Exhibits 119: Sartorius AG - Segment focus
Exhibits 120: TCS Biosciences Ltd. - Overview
Exhibits 121: TCS Biosciences Ltd. - Product / Service
Exhibits 122: TCS Biosciences Ltd. - Key offerings
Exhibits 123: Thermo Fisher Scientific Inc. - Overview
Exhibits 124: Thermo Fisher Scientific Inc. - Business segments
Exhibits 125: Thermo Fisher Scientific Inc. - Key news
Exhibits 126: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 127: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 128: Inclusions checklist
Exhibits 129: Exclusions checklist
Exhibits 130: Currency conversion rates for US$
Exhibits 131: Research methodology
Exhibits 132: Validation techniques employed for market sizing
Exhibits 133: Information sources
Exhibits 134: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global fetal bovine serum market: Access Biologicals LLC, Animal Technologies Inc., Anzco Foods Ltd, Atlas Biologicals Inc., Axil Scientific Pte Ltd., Bio Techne Corp., BIOWEST SAS, Corning Inc., Danaher Corp., GeminiBio, HiMedia Laboratories Pvt. Ltd., Merck KGaA, Moregate Biotech, Nucleus Biologics, PAN Biotech GmbH, Peak Serum Inc., Rocky Mountain Biologicals LLC., Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Tissue Culture Biologicals.

Commenting on the report, an analyst from the publishing company said: "The latest trend gaining momentum in the market is growing application in cell-based pharmaceutical research."

According to the report, one of the major drivers for this market is the rising adoption of stem cell applications.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.